Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Nara Smith, Lupus and Eczema
Nara Smith Details Gruesome Eczema Flare-Up That Left Her Body 'Oozing' and 'Swollen' — and How She Found Relief in Lupus Diagnosis
Nara Smith shared images and a lengthy caption detailing the health challenges she's experienced in the three years since her eczema started "flaring up severely" and how she found relief in her lupus diagnosis.
Nara Smith Is Opening Up About Her Struggles With Eczema and Lupus
Nara Smith shared pictures of her recent eczema flare-ups on Instagram, where the model got candid about her journey with the skin condition.
Nara Smith Gets Candid About Severe Eczema Flare Ups
Being a social media star may seem like the high life but Nara Smith, fashion model-turned-TikTok creator just pulled back the curtain on all that appears glitz and glam by getting candid about her struggles with eczema, which, more recently, led to a lupus diagnosis.
'My eyes were swollen shut' – Nara Smith on her struggles with eczema
Famed for her incredible IG cook-a-longs, model Nara Smith has been opening up about her battles with skin condition eczema. Posting to her 4.5 million followers, the 23-year-old detailed her journey with the autoimmune disease as well as Lupus,
AnaptysBio to Drop Eczema Drug Candidate
AnaptysBio to abandon eczema drug development after mid-stage trial failure
AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a mid-stage trial, the company said on Wednesday, dragging its shares nearly 40% lower.
AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall
AnaptysBio shares plummeted in premarket trading Wednesday after the company said it will discontinue its dermatitis treatment after the drug failed to meet its targets in recent trials. Shares fell over 39% to $14 ahead of the morning bell.
AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data
AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary endpoints in any of the doses studied in the ARISE-AD trial as a monotherapy for moderate-to-severe atopic dermatitis (AD) or eczema.
2d
An All-Weather Guide To Eczema And Your Skin
Discover how different types of weather, from scorching heat to chilly winds, can wreak havoc on your skin and learn ...
FierceBiotech
1d
Q32's stock plunges in wake of phase 2 eczema fail for anti-IL-7R antibody
Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...
6d
I Have Eczema, and These Are the Products That Don't Bother My Skin
These ten essentials keep my skin hydrated, soothed, and protected from inflammation, itchiness, and occasional scaliness.
7d
on MSN
Mum cries over skin balm that cleared up baby’s extreme eczema overnight
But parents have been swearing by Balmond’s Skin Salvation, an all-natural balm made with potent earth-kind ingredients. Mum ...
1d
Unmet needs in the chronic hand eczema treatment landscape
Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.
1d
The best moisturisers for eczema, according to experts
Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...
Onlymyhealth
1d
Try THIS If You Have Eczema Or Psoriasis
Managing eczema or psoriasis requires a wide approach Hence by focusing on sugar control a high-protein diet and incorporating diluted apple cider vinegar you can take meaningful steps toward healthie ...
22h
Investors Slaughter Q32 Bio On A 'Messy' Update In Eczema, Alopecia Treatment
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Atopic dermatitis
AnaptysBio
Nara Smith
Q32
Hair loss
Feedback